Cargando…

Transient anabolic effects accompany epidermal growth factor receptor signal activation in articular cartilage in vivo

INTRODUCTION: Signals from the epidermal growth factor receptor (EGFR) have typically been considered to provide catabolic activities in articular cartilage, and accordingly have been suggested to have a causal role in osteoarthritis progression. The aim of this study was to determine in vivo roles...

Descripción completa

Detalles Bibliográficos
Autores principales: Shepard, John B, Jeong, Jae-Wook, Maihle, Nita J, O'Brien, Sean, Dealy, Caroline N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060279/
https://www.ncbi.nlm.nih.gov/pubmed/23705804
http://dx.doi.org/10.1186/ar4233
_version_ 1782321350514311168
author Shepard, John B
Jeong, Jae-Wook
Maihle, Nita J
O'Brien, Sean
Dealy, Caroline N
author_facet Shepard, John B
Jeong, Jae-Wook
Maihle, Nita J
O'Brien, Sean
Dealy, Caroline N
author_sort Shepard, John B
collection PubMed
description INTRODUCTION: Signals from the epidermal growth factor receptor (EGFR) have typically been considered to provide catabolic activities in articular cartilage, and accordingly have been suggested to have a causal role in osteoarthritis progression. The aim of this study was to determine in vivo roles for endogenous EGFR signal activation in articular cartilage. METHODS: Transgenic mice with conditional, limb-targeted deletion of the endogenous intracellular EGFR inhibitor Mig-6 were generated using CreLoxP (Mig-6-flox; Prx1Cre) recombination. Histology, histochemical staining and immunohistochemistry were used to confirm activation of EGFR signaling in the articular cartilage and joints, and to analyze phenotypic consequences of Mig-6 loss on articular cartilage morphology, proliferation, expression of progenitor cell markers, presence of chondrocyte hypertrophy and degradation of articular cartilage matrix. RESULTS: The articular cartilage of Mig-6-conditional knockout (Mig-6-cko) mice was dramatically and significantly thicker than normal articular cartilage at 6 and 12 weeks of age. Mig-6-cko articular cartilage contained a population of chondrocytes in which EGFR signaling was activated, and which were three to four times more proliferative than normal Mig-6-flox articular chondrocytes. These cells expressed high levels of the master chondrogenic regulatory factor Sox9, as well as high levels of putative progenitor cell markers including superficial zone protein (SZP), growth and differentiation factor-5 (GDF-5) and Notch1. Expression levels were also high for activated β-catenin and the transforming growth factor beta (TGF-β) mediators phospho-Smad2/3 (pSmad2/3). Anabolic effects of EGFR activation in articular cartilage were followed by catabolic events, including matrix degradation, as determined by accumulation of aggrecan cleavage fragments, and onset of hypertrophy as determined by type × collagen expression. By 16 weeks of age, the articular cartilage of Mig-6-cko knees was no longer thickened and was degenerating. CONCLUSIONS: These results demonstrate unexpected anabolic effects of EGFR signal activation in articular cartilage, and suggest the hypothesis that these effects may promote the expansion and/or activity of an endogenous EGFR-responsive cell population within the articular cartilage.
format Online
Article
Text
id pubmed-4060279
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40602792014-06-17 Transient anabolic effects accompany epidermal growth factor receptor signal activation in articular cartilage in vivo Shepard, John B Jeong, Jae-Wook Maihle, Nita J O'Brien, Sean Dealy, Caroline N Arthritis Res Ther Research Article INTRODUCTION: Signals from the epidermal growth factor receptor (EGFR) have typically been considered to provide catabolic activities in articular cartilage, and accordingly have been suggested to have a causal role in osteoarthritis progression. The aim of this study was to determine in vivo roles for endogenous EGFR signal activation in articular cartilage. METHODS: Transgenic mice with conditional, limb-targeted deletion of the endogenous intracellular EGFR inhibitor Mig-6 were generated using CreLoxP (Mig-6-flox; Prx1Cre) recombination. Histology, histochemical staining and immunohistochemistry were used to confirm activation of EGFR signaling in the articular cartilage and joints, and to analyze phenotypic consequences of Mig-6 loss on articular cartilage morphology, proliferation, expression of progenitor cell markers, presence of chondrocyte hypertrophy and degradation of articular cartilage matrix. RESULTS: The articular cartilage of Mig-6-conditional knockout (Mig-6-cko) mice was dramatically and significantly thicker than normal articular cartilage at 6 and 12 weeks of age. Mig-6-cko articular cartilage contained a population of chondrocytes in which EGFR signaling was activated, and which were three to four times more proliferative than normal Mig-6-flox articular chondrocytes. These cells expressed high levels of the master chondrogenic regulatory factor Sox9, as well as high levels of putative progenitor cell markers including superficial zone protein (SZP), growth and differentiation factor-5 (GDF-5) and Notch1. Expression levels were also high for activated β-catenin and the transforming growth factor beta (TGF-β) mediators phospho-Smad2/3 (pSmad2/3). Anabolic effects of EGFR activation in articular cartilage were followed by catabolic events, including matrix degradation, as determined by accumulation of aggrecan cleavage fragments, and onset of hypertrophy as determined by type × collagen expression. By 16 weeks of age, the articular cartilage of Mig-6-cko knees was no longer thickened and was degenerating. CONCLUSIONS: These results demonstrate unexpected anabolic effects of EGFR signal activation in articular cartilage, and suggest the hypothesis that these effects may promote the expansion and/or activity of an endogenous EGFR-responsive cell population within the articular cartilage. BioMed Central 2013 2013-05-25 /pmc/articles/PMC4060279/ /pubmed/23705804 http://dx.doi.org/10.1186/ar4233 Text en Copyright © 2013 Shepard et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Shepard, John B
Jeong, Jae-Wook
Maihle, Nita J
O'Brien, Sean
Dealy, Caroline N
Transient anabolic effects accompany epidermal growth factor receptor signal activation in articular cartilage in vivo
title Transient anabolic effects accompany epidermal growth factor receptor signal activation in articular cartilage in vivo
title_full Transient anabolic effects accompany epidermal growth factor receptor signal activation in articular cartilage in vivo
title_fullStr Transient anabolic effects accompany epidermal growth factor receptor signal activation in articular cartilage in vivo
title_full_unstemmed Transient anabolic effects accompany epidermal growth factor receptor signal activation in articular cartilage in vivo
title_short Transient anabolic effects accompany epidermal growth factor receptor signal activation in articular cartilage in vivo
title_sort transient anabolic effects accompany epidermal growth factor receptor signal activation in articular cartilage in vivo
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060279/
https://www.ncbi.nlm.nih.gov/pubmed/23705804
http://dx.doi.org/10.1186/ar4233
work_keys_str_mv AT shepardjohnb transientanaboliceffectsaccompanyepidermalgrowthfactorreceptorsignalactivationinarticularcartilageinvivo
AT jeongjaewook transientanaboliceffectsaccompanyepidermalgrowthfactorreceptorsignalactivationinarticularcartilageinvivo
AT maihlenitaj transientanaboliceffectsaccompanyepidermalgrowthfactorreceptorsignalactivationinarticularcartilageinvivo
AT obriensean transientanaboliceffectsaccompanyepidermalgrowthfactorreceptorsignalactivationinarticularcartilageinvivo
AT dealycarolinen transientanaboliceffectsaccompanyepidermalgrowthfactorreceptorsignalactivationinarticularcartilageinvivo